BioNxt Solutions Inc. (OTCMKTS:BNXTF – Get Free Report) saw a significant increase in short interest in the month of October. As of October 30th, there was short interest totaling 3,000 shares, an increase of 200.0% from the October 15th total of 1,000 shares. Currently, 0.0% of the shares of the stock are sold short. Based on an average trading volume of 10,902 shares, the days-to-cover ratio is currently 0.3 days.
BioNxt Solutions Stock Performance
Shares of OTCMKTS:BNXTF opened at $0.15 on Friday. The company’s fifty day moving average is $0.23 and its 200-day moving average is $0.30. BioNxt Solutions has a 52 week low of $0.10 and a 52 week high of $0.57. The company has a market capitalization of $20.95 million, a PE ratio of -3.08 and a beta of 0.85.
BioNxt Solutions (OTCMKTS:BNXTF – Get Free Report) last announced its earnings results on Friday, August 28th. The company reported ($0.01) earnings per share (EPS) for the quarter.
BioNxt Solutions Company Profile
BioNxt Solutions Inc. is a Canadian life sciences company focused on developing pharmaceutical and diagnostic products using alternative drug-delivery technologies. Its platform work includes orally dissolvable films, transdermal delivery systems and related formulations intended to improve the convenience, dosing and absorption of established medicines. The company’s development programs have included therapies for neurological and other medical conditions, as well as diagnostic applications. BioNxt has emphasized the development, testing and potential commercialization of products through a combination of internal research and collaborations with external laboratories and manufacturing partners.
See Also
- Five stocks we like better than BioNxt Solutions
- Nu Holdings Earnings Show a Compounder Priced Like a Brazil Bet
- Game On: The Hidden Value in Take-Two’s Stock
- LightPath Technologies’ Record Backlog Highlights a Bigger Defense Opportunity
- A 10-Stock Strategy That Balances AI Growth With Cash Flow
Receive News & Ratings for BioNxt Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioNxt Solutions and related companies with MarketBeat.com's FREE daily email newsletter.
